INPLASY202270049

Efficacy and safety of Apatinib for the treatment of advanced or recurrent cervical cancer: A single-arm meta-analysis among Chinese patients

Keywords: Apatinib, advanced/recurrent cervical cancer, tumor response, survival, adverse events